Moreover, STAT3/Rabs-mediated exosome release was correlated with a more aggressive and chemoresistant cancer phenotype under hypoxic conditions [53] and a recent study demonstrated a role for Rab18 in resistance to cisplatin-induced apoptosis [54]. Here, STAT3 is linked to cancer.